Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: 7-Epiclindamycin hydrochloride
RN: 17431-55-9
InChIKey: AUODDLQVRAJAJM-BOMBIWCESA-N

Classification Code

  • Drug / Therapeutic Agent

Molecular Formula

  • C18-H33-Cl-N2-O5-S.Cl-H

Molecular Weight

  • 461.448
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • 7-Epiclindamycin hydrochloride

Synonyms

  • 7-Deoxy-7(R)-chlorolincomycin hydrochloride
  • 7-Epiclindamycin HCl

Systematic Names

  • D-erythro-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2S-trans)-
  • D-erythro-D-galacto-Octopyranoside, methyl 7-(S)-chloro-6,7,8-trideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, hydrochloride, trans-alpha-

Registry Numbers

CAS Registry Number

  • 17431-55-9

System Generated Number

  • 0017431559

Molecular Formulas

Molecular Formula

  • C18-H33-Cl-N2-O5-S.Cl-H

Molecular Formula Fragments

  • C18-H33-Cl-N2-O5-S
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C18H33ClN2O5S.ClH/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4;/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25);1H/t9-,10-,11+,12-,13+,14-,15-,16-,18-;/m1./s1

InChIKey

AUODDLQVRAJAJM-BOMBIWCESA-N

Smiles

C1[C@H]([N@@](C)C[C@@H]1CCC)C(N[C@@H]([C@H]1O[C@H](SC)[C@H](O)[C@H]([C@H]1O)O)[C@H](Cl)C)=O.Cl

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 262mg/kg (262mg/kg)   Antimicrobial Agents and Chemotherapy Vol. -, Pg. 727, 1966.
mouse LD50 intravenous 143mg/kg (143mg/kg)   Antimicrobial Agents and Chemotherapy Vol. -, Pg. 727, 1966.
mouse LD50 oral 1479mg/kg (1479mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 16, Pg. 773, 1969.
mouse LD50 subcutaneous 656mg/kg (656mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 16, Pg. 773, 1969.
rat LD50 intraperitoneal 279mg/kg (279mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 16, Pg. 773, 1969.
rat LD50 oral 4022mg/kg (4022mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 16, Pg. 773, 1969.
rat LD50 subcutaneous 891mg/kg (891mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 16, Pg. 773, 1969.